Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001346824-26-000068·RA CAPITAL MANAGEMENT, L.P.
Schedule 13D ownership disclosure
Tyra Biosciences Inc
Common Stock, $0.0001 par value per share · CUSIP: 90240B106
Event date: 2026-03-04
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- RA Capital Management, L.P.Reported CIK 0001346824
Shares: 12,266,575.00 · Class: 21.2%
- Peter KolchinskyReported CIK 0001384859
Shares: 12,266,575.00 · Class: 21.2%
- Rajeev ShahReported CIK 0001619841
Shares: 12,266,575.00 · Class: 21.2%
- RA Capital Healthcare Fund, L.P.Reported CIK 0001315082
Shares: 10,259,291.00 · Class: 17.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001346824-26-000068
- Form type
- SCHEDULE 13D/A
- Filer
- RA CAPITAL MANAGEMENT, L.P.
- CIK
- CIK 1346824
- Filed
- Mar 06, 2026
- Reporting period
- Mar 04, 2026
- Description
- Schedule 13D beneficial ownership